30th May 2011
Melbourne medical researchers are leading a worldwide trial on stroke therapy that could mean the difference between a patient walking out of hospital within a few days or being left permanently disabled.
Each year 60,000 Australians suffer a stroke, but only half of them get to hospital in time to be considered for a clot-busting drug that stops the brain being starved of oxygen. That means it keeps brain tissue alive, something that makes a massive difference to how well a stroke patient recovers.
The Melbourne trial’s aimed at extending the crucial period in which that drug can be administered effectively, as Lisa Whitehead reports.
Melbourne patients will be the first in the world to trial new technology to combat strokes.